Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jenny Frenkel"'
Autor:
Naomi Goldfinger, Rivka Yona, Joy Kahn, Dan Sherman, Varda Rotter, Naomi Rahimi-Levene, Shoshana Peller, Tsvee Lapidot, Lior Nissim, Jenny Frenkel
Publikováno v:
Oncogene. 22:4648-4655
The p53 tumor suppressor gene was found to play a role in the differentiation of several tissue types. We report here that p53-dependent apoptosis plays a role in the final stages of physiological differentiation of normoblasts, resulting in nuclear
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b086e2a2896b32c291109c3910ccf190
https://doi.org/10.1038/sj.onc.1206541
https://doi.org/10.1038/sj.onc.1206541
Publikováno v:
European Journal of Endocrinology. 134:716-719
Klinger B, Silbergeld A, Deghenghi R, Frenkel J, Laron Z. Desensitization from long-term intranasal treatment with hexarelin does not interfere with the biological effects of this growth hormonereleasing peptide in short children. Eur J Endocrinol 19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::997040eb21cb223a13e4d96f7915097d
https://doi.org/10.1530/eje.0.1340716
https://doi.org/10.1530/eje.0.1340716
Autor:
Zvi Laron, B. Klinger, Vincent Lengerts, Patrick Wuthrich, Lrit Gil‐Ad, Jenny Frenkel, Francois Boutignon, Ernesto Lubin, Romano Deghenghi
Publikováno v:
Clinical Endocrinology. 41:539-541
OBJECTIVE Hexarelin is a new synthetic growth hormone releasing peptide. We have tested the efficacy of intranasal (i.n.) administration of hexarelin to stimulate plasma GH and have compared this to the intravenous (i.v.) administration of the peptid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b671cd0d8a1c835a5967f401647e5165
https://doi.org/10.1111/j.1365-2265.1994.tb02589.x
https://doi.org/10.1111/j.1365-2265.1994.tb02589.x
Autor:
Jenny Frenkel, Dan Sherman, Daniel Yair, Michael J. Kupferminc, Talma Eshed‐Englender, Eli Geva
Publikováno v:
American journal of reproductive immunology (New York, N.Y. : 1989). 45(3)
PROBLEM: To investigate whether inhibin A, inhibin B, and activin A serum levels are altered in women with preeclampsia. METHOD OF STUDY: Serum samples of 20 women with preeclampsia (study group) and 20 normotensive pregnant women, matched for matern
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::167eef22a26a26daf89a479925563de2
https://pubmed.ncbi.nlm.nih.gov/11270644
https://pubmed.ncbi.nlm.nih.gov/11270644
Publikováno v:
Growth Hormone Secretagogues ISBN: 9781461275268
Hexarelin is a synthetic hexapeptide (His-D-2-methyl-Trp-Ala-Trp-D-Phe- Lys-NH2) that stimulates the release of pituitary growth hormone both in vitro (1) and in vivo (2). It has proved active also in adult men (3) even when administered by the oral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::11c1147a0778a3c84018a87598e004fc
https://doi.org/10.1007/978-1-4612-2396-2_24
https://doi.org/10.1007/978-1-4612-2396-2_24
Publikováno v:
Clinical endocrinology. 43(5)
Summary OBJECTIVE Hexarelin is a recently synthesized small growth hormone releasing peptide (GHRP) (His-D-methyl-Trp-Ala-Trp-D-Phe-Lys-NH2). It Is actlve by intra-venous, oral and intranasal administration In animals and man. The aim of this study w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::334d2bfa457be0852bc3692142c1984d
https://pubmed.ncbi.nlm.nih.gov/8548949
https://pubmed.ncbi.nlm.nih.gov/8548949
Publikováno v:
Journal of pediatric endocrinologymetabolism : JPEM. 8(1)
Twice or three times daily intranasal administration of the hexapeptide hexarelin for 7 days to children with short stature and normal growth hormone (GH) secretion evoked a significant rise in serum levels of insulin-like growth factor-1 (IGF-1) and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91e9384caaed9884d4d25af34ed874d7
https://pubmed.ncbi.nlm.nih.gov/7584696
https://pubmed.ncbi.nlm.nih.gov/7584696